G1 Therapeutics, Inc. is a commercial-stage oncology company focused on the development and commercialization of next generation anti-cancer therapies. Led by a team with a deep understanding of the biology of cancer and extensive development and commercialization expertise, G1 is advancing its mission to improve the lives of those affected by cancer, including by commercializing the Company’s first commercial product, COSELA® (trilaciclib). G1 is also executing a development program, with a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics. View our social community guidelines here: https://www.g1therapeutics.com/social-guidelines
View Top Employees from G1 Therapeutics, Inc.Website | http://www.g1therapeutics.com |
Ticker | GTHX |
Revenue | $24.2 million |
Funding | $206.2 million |
Employees | 149 (149 on RocketReach) |
Founded | 2008 |
Phone | (919) 213-9835 |
Fax | (919) 741-5830 |
Technologies |
JavaScript,
HTML,
Google Analytics
+28 more
(view full list)
|
Industry | Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Developer Platform, Software, Medical, Health Care, Therapeutics |
Web Rank | 6 Million |
Keywords | G1 Therapeutics, Trilaciclib, G1 Theraputics, G1t48, "Investor Relations" And "Asco" |
Competitors | Epizyme, Karyopharm Therapeutics Inc., ORIC Pharmaceuticals Inc., Otonomy, Inc, ProNAi Therapeutics |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 54138 Companies, NAICS Code 5413 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular G1 Therapeutics, Inc. employee's phone or email?
The G1 Therapeutics, Inc. annual revenue was $24.2 million in 2024.
Jack Bailey is the CEO of G1 Therapeutics, Inc..
149 people are employed at G1 Therapeutics, Inc..
The NAICS codes for G1 Therapeutics, Inc. are [32, 325, 54138, 5413, 541, 54].
The SIC codes for G1 Therapeutics, Inc. are [28, 283].